Physician profile
Bart A Grelinger
NPI 1730184433
$625.10
in general payments reported to CMS, 2019-2025
19 companies · $82.19 in 2025
The $82.19 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $128 · 2023: $101 · 2024: $162 · 2025: $82.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $96.60 | 2021-2024 | Vyepti |
| Abbvie INC. | $57.52 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $55.54 | 2024 | |
| Globus Medical, INC. | $54.69 | 2025 | Senza |
| Biogen, INC. | $45.81 | 2021-2025 | Qalsody, Spinraza |
| Ucb, INC. | $45.37 | 2021-2024 | Rystiggo |
| Argenx US, INC. | $34.29 | 2023 | Vyvgart |
| Medtronic, INC. | $27.52 | 2022-2024 | Synchromedii |
| Janssen Pharmaceuticals, INC | $21.72 | 2021 | |
| Celgene Corporation | $21.40 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $21.02 | 2021 | |
| Nevro Corp. | $19.95 | 2022 | |
| Genentech USA, INC. | $19.54 | 2024 | Ocrevus Zunovo, Ocrevus |
| Banner Life Sciences, LLC | $19.48 | 2023 | |
| Allergan, INC. | $19.17 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $18.55 | 2023 | Nourianz |
| Horizon Therapeutics Plc | $18.04 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.17 | 2023 | Magnetom Altea |
| Ge Healthcare | $12.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Grelinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.